IV Nutrient Therapy and the Skeptics: An Honest Conversation

If you have spent any time researching IV therapy, you have almost certainly come across a physician or medical commentator dismissing it. The arguments tend to follow a predictable pattern. There is no evidence that it works. You are just paying to make expensive urine. It is a placebo. Save your money and eat a salad.

Some of that skepticism is legitimate. Some of it reflects the same blind spots that have historically slowed the acceptance of acupuncture, naturopathy, chiropractic care, and other approaches that are now widely used and increasingly covered by insurance. It is worth looking at the actual arguments rather than accepting either the marketing or the dismissal at face value.

The "You Just Pee It Out" Argument

This one gets repeated often enough to warrant a direct response.

The claim is that water-soluble vitamins like Vitamin C and B vitamins are simply excreted when taken in excess, making supplementation pointless. This is partially true and frequently misapplied.

Yes, your body excretes water-soluble vitamins it does not need. It does this regardless of whether they arrived orally or intravenously. The relevant question is not whether excess is excreted but whether adequate amounts reached circulation in the first place.

Oral vitamin absorption is variable. It depends on gut health, the form of the supplement, what else is in your digestive system, age-related changes in absorption, enzyme function, medication interactions, and individual metabolic differences (Gröber et al., 2020, as cited in PMC, 2025). For a person with optimal digestion, no absorption concerns, and consistent dietary intake, oral supplementation may work well. For a significant portion of people, it does not, and the excess excretion argument tells you nothing useful about whether those people are actually absorbing what they take.

IV delivery bypasses all of those variables. What goes in reaches circulation at a predictable concentration. Studies have demonstrated that IV Vitamin C achieves plasma concentrations 50 to 100 times higher than what is achievable through oral ingestion (Inside Health Clinic, 2026). For clients with pernicious anemia who cannot absorb B12 through the gut, intramuscular or IV delivery is the medically accepted standard of treatment. Nobody dismisses that application as making expensive urine.

The argument that excess excretion proves IV therapy is pointless applies equally to oral supplements. It is not a meaningful critique of the delivery method specifically.

The Evidence Problem

The stronger version of the skeptical argument is that large-scale randomized controlled trials specifically examining IV nutrient therapy in healthy adults are scarce, and that without such evidence, clinical benefit cannot be established.

This is a fair point. The evidence base for wellness IV therapy is less robust than that for pharmaceutical interventions, and we have said so directly in our other posts discussing individual ingredients. We are not going to pretend the research is stronger than it is.

What is worth examining is why that evidence gap exists.

Clinical research at scale is expensive. The funding structures that support large randomized controlled trials are built primarily around pharmaceutical development, where patent protection creates financial returns that justify the investment. Nutrients cannot be patented. Magnesium, Vitamin C, B12, and glutathione are off-patent compounds with no commercial exclusivity. The financial incentive to run expensive phase III trials on IV nutrient combinations is limited, which means the evidence base develops more slowly than it would for a drug with commercial returns attached.

This is not evidence that the therapies do not work. It is evidence that our research infrastructure prioritizes certain kinds of knowledge over others. The absence of a large randomized trial is not evidence of no effect, and treating it as such would apply a standard that much of accepted medical practice would not survive.

On Placebo

The placebo argument deserves particular attention because it is more interesting than the dismissal usually acknowledges.

A 2009 fibromyalgia study found that participants receiving Myers Cocktail experienced significant improvements in pain, depression, and quality of life after eight weeks. The placebo group also reported significant improvements, leading the authors to note a strong placebo effect and describe the actual effectiveness as uncertain (Ali et al., 2009, as cited in Mayo Clinic Press, 2024).

This finding gets cited frequently as evidence that IV therapy does not work. It is worth sitting with what it actually shows.

Both groups got meaningfully better. The intervention group and the placebo group both reported real improvements in pain and quality of life over eight weeks. The conclusion drawn was that IV therapy is therefore ineffective because the placebo group also improved. A different reading of the same data is that whatever happened in that room, for those people, over those eight weeks, produced real and meaningful improvements in how they felt.

Placebo response is a real physiological phenomenon. It involves measurable changes in brain chemistry, immune function, and pain perception. It is not imaginary. Dismissing an outcome because a placebo contributed to it assumes that a placebo is not a legitimate mechanism of benefit, which the evidence does not support. A therapy that produces meaningful improvements partly through placebo mechanisms is still producing meaningful improvements.

There is also a broader question worth asking. If a person feels meaningfully better after a session, sleeps more soundly, has more energy for the following three days, and reports improved wellbeing, at what point does the mechanism matter more than the outcome? We are not arguing that a placebo explains everything or that the mechanism is irrelevant. We argue that the reflexive dismissal of any therapy in which placebo effects are observed is not as scientifically rigorous as it presents itself to be.

What the Mainstream Gets Right

In the interest of balance, the skeptics are correct about some things.

IV therapy is not appropriate for everyone. It carries real clinical risks when administered without proper screening, by unqualified practitioners, or outside appropriate clinical oversight. The wellness IV industry has providers who overstate benefits, understate risks, and prioritize revenue over clinical rigour. That criticism is valid, and it is one reason clinical standards, regulated nursing oversight, and NP medical directives matter.

The skeptics are also correct that IV therapy is not a substitute for addressing the root causes of poor health. Chronic dehydration caused by consistently poor fluid intake is better addressed by drinking more water than by regular IV sessions. Nutrient deficiencies caused by consistently poor dietary intake are better addressed by improving diet than by bypassing it indefinitely. IV therapy is a supportive tool, not a lifestyle replacement.

Where mainstream medicine tends to go wrong is in treating the absence of large-scale trial evidence as equivalent to evidence of absence, and in dismissing the consistent subjective reports of people who have experienced meaningful benefit as simply a placebo, as though that settles the question rather than opening it.

Where Hyndford Hydration Stands

We think IV and IM therapy is a genuinely useful supportive tool for the right clients in the right circumstances. We also think the industry does itself no favours by overpromising, making therapeutic claims unsupported by the evidence, and dismissing legitimate skepticism rather than engaging with it honestly.

Our approach is to be straight about what the evidence supports, clear about where it is still developing, and honest about what we can and cannot offer. If IV therapy is not the right fit for your situation, we will tell you that.

IV and IM therapy is supportive in nature. We do not diagnose or treat medical conditions, and we will not claim to do so.

All sessions are delivered to your door with no mandatory consultation fees for most clients. Clinical screening is completed before every visit under a valid BC medical directive. Travel is included within our Nanaimo service area. Outside Lantzville to Cedar? Get in touch for a travel quote.

Have a look at our Signature Infusions or get in touch with questions.

Ready? Reserve your infusion today.

References

Ali, A., Njike, V. Y., Northrup, V., Sabina, A. B., Williams, A. L., Liberti, L. S., Perlman, A. I., Adelson, H., & Katz, D. L. (2009). Intravenous micronutrient therapy (Myers' cocktail) for fibromyalgia: A placebo-controlled pilot study. Journal of Alternative and Complementary Medicine, 15(3), 247-257.

Inside Health Clinic. (2026). IV the

rapy vs. oral supplements: Which is more effective? https://www.insidehealthclinic.com/2026/01/iv-therapy-vs-oral-supplements-which-is-more-effective/

Mayo Clinic Press. (2024). IV vitamin therapy: Understanding the lack of proven benefit and potential risks. https://mcpress.mayoclinic.org/living-well/iv-vitamin-therapy-understanding-the-lack-of-proven-benefit-and-potential-risks-of-this-health-fad/

PMC. (2025). To IV or not to IV: The science behind intravenous vitamin therapy. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12182718/